Trial intelligence / Profile preview

Adjuvanted vs Inactivated Influenza Vaccine in Hutterite Children

NCT02871206Phase 4Completed

Sponsor
McMaster University
Start
Nov 2016
Primary completion
Jun 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, randomised trial of Fluzone Trivalent in influenza (2 arms), sponsored by McMaster University. Primary endpoint: Laboratory-confirmed influenza infection up to 3 years. Started Nov 2016; status: completed.

02

Drugs

Fluzone Trivalent
03

Conditions

influenza

Beyond the preview

Go deeper on NCT02871206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02871206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call